IE42137B1 - Compositions containing piperidyl xanthenes,thioxanthenes and dibenzozepins - Google Patents

Compositions containing piperidyl xanthenes,thioxanthenes and dibenzozepins

Info

Publication number
IE42137B1
IE42137B1 IE2398/75A IE239875A IE42137B1 IE 42137 B1 IE42137 B1 IE 42137B1 IE 2398/75 A IE2398/75 A IE 2398/75A IE 239875 A IE239875 A IE 239875A IE 42137 B1 IE42137 B1 IE 42137B1
Authority
IE
Ireland
Prior art keywords
chloro
hydrogen
compound according
mol
methyl
Prior art date
Application number
IE2398/75A
Other languages
English (en)
Other versions
IE42137L (en
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of IE42137L publication Critical patent/IE42137L/xx
Publication of IE42137B1 publication Critical patent/IE42137B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IE2398/75A 1974-11-06 1975-11-04 Compositions containing piperidyl xanthenes,thioxanthenes and dibenzozepins IE42137B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52121674A 1974-11-06 1974-11-06

Publications (2)

Publication Number Publication Date
IE42137L IE42137L (en) 1976-05-06
IE42137B1 true IE42137B1 (en) 1980-06-04

Family

ID=24075868

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2398/75A IE42137B1 (en) 1974-11-06 1975-11-04 Compositions containing piperidyl xanthenes,thioxanthenes and dibenzozepins

Country Status (17)

Country Link
JP (1) JPS5826754B2 (fr)
AU (1) AU498298B2 (fr)
BE (1) BE835224A (fr)
CA (1) CA1055945A (fr)
CH (1) CH624403A5 (fr)
DE (1) DE2549841A1 (fr)
DK (1) DK139429B (fr)
ES (1) ES442357A1 (fr)
FR (1) FR2290202A1 (fr)
HU (1) HU174639B (fr)
IE (1) IE42137B1 (fr)
IL (1) IL48400A (fr)
LU (1) LU73714A1 (fr)
NL (1) NL7512974A (fr)
NZ (1) NZ179139A (fr)
PH (1) PH12158A (fr)
ZA (1) ZA756550B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7511064B2 (en) 2001-10-25 2009-03-31 Biofrontera Bioscience Gmbh Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2357251A1 (fr) * 1976-07-09 1978-02-03 Merck & Co Inc 1-methyl-4-(2-carboxy-1-thioxanthan-9-ylidene)-piperidine
US4073912A (en) * 1976-10-12 1978-02-14 Smithkline Corporation Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof
US4089961A (en) * 1976-11-08 1978-05-16 Smithkline Corporation Antipsychotically useful quinolizidylidene derivatives of xanthenes, thioxanthenes and dibenzoxepins
NZ189108A (en) * 1977-12-29 1982-02-23 Kefalas As 2-methylthio-6-fluoro-9-(1-methyl-4-piperidylidene)-thioxanthene and pharmaceutical compositions intermediate 2-methylthio-6-fluoro-9-(1-methyl-4-piperidyl)-thioxanthen-9-ol
US4777177A (en) * 1984-10-19 1988-10-11 Ciba-Geigy Corporation Pesticidal thioxanthen-9-ylidenepiperidines
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
CA2004211A1 (fr) * 1988-11-30 1990-05-31 Masataka Syoji Derives de piperidine et hypotenseurs les contenant
EP1306376A1 (fr) * 2001-10-25 2003-05-02 Biofrontera Pharmaceuticals AG Dérives de 4-(thio- or selenoxanthene-9-ylidene)-piperidine ou acridine et leur application comme antagonistes selectives de 5-HT2B
WO2005003131A1 (fr) 2003-06-27 2005-01-13 Janssen Pharmaceutica N.V. Modulateurs du recepteur opioide $g(d) tricycliques
AU2005335481A1 (en) 2004-08-05 2007-04-19 Janssen Pharmaceutica N.V. Tricyclic delta- opioid modulators
EP1833825A1 (fr) 2004-12-22 2007-09-19 Janssen Pharmaceutica N.V. Modulateurs des recepteurs opioides-delta tricycliques
AU2005319059A1 (en) * 2004-12-22 2006-06-29 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
ATE432279T1 (de) 2004-12-22 2009-06-15 Janssen Pharmaceutica Nv Tricyclische delta-opioid-modulatoren
MX2007008286A (es) 2005-01-06 2007-11-12 Johnson & Johnson Moduladores delta-opioides triciclicos.
TW200716134A (en) 2005-06-16 2007-05-01 Janssen Pharmaceutica Nv Tricyclic opioid modulators
CA2664345A1 (fr) 2006-09-29 2008-04-03 Nippon Zoki Pharmaceutical Co., Ltd. Derive de l'oxepine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL260070A (fr) * 1960-02-25
NL283292A (fr) * 1961-09-29
DE1670118A1 (de) * 1966-07-22 1970-11-05 Boehringer Mannheim Gmbh Verfahren zur Herstellung neuer Derivate des 6,11-Dihydro-dibenz[b,e]oxepins und ihrer Salze
US3470188A (en) * 1967-01-05 1969-09-30 Smithkline Corp 9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
JPS5018478A (fr) * 1973-05-17 1975-02-26

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7511064B2 (en) 2001-10-25 2009-03-31 Biofrontera Bioscience Gmbh Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist

Also Published As

Publication number Publication date
DK139429C (fr) 1979-08-06
ES442357A1 (es) 1977-04-01
IL48400A0 (en) 1976-01-30
NZ179139A (en) 1978-04-28
NL7512974A (nl) 1976-05-10
FR2290202A1 (fr) 1976-06-04
FR2290202B1 (fr) 1980-05-23
PH12158A (en) 1978-11-10
IE42137L (en) 1976-05-06
LU73714A1 (fr) 1976-06-11
AU8624775A (en) 1977-05-05
JPS5826754B2 (ja) 1983-06-04
HU174639B (hu) 1980-02-28
DE2549841C2 (fr) 1988-07-07
DK139429B (da) 1979-02-19
BE835224A (fr) 1976-05-04
AU498298B2 (en) 1979-03-01
ZA756550B (en) 1976-09-29
IL48400A (en) 1979-01-31
CH624403A5 (en) 1981-07-31
CA1055945A (fr) 1979-06-05
DK495775A (fr) 1976-05-07
JPS5170768A (fr) 1976-06-18
DE2549841A1 (de) 1976-05-13

Similar Documents

Publication Publication Date Title
US4086350A (en) Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
IE42137B1 (en) Compositions containing piperidyl xanthenes,thioxanthenes and dibenzozepins
US3014911A (en) Derivatives of dibenzo[a, e]cycloheptatriene
DE69331888T2 (de) Bicyclische Pyridinderivate, Verfahren zu ihrer Herstellung, Zwischenprodukte, ihre Anwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen
NZ236117A (en) Indole derivatives and pharmaceutical compositions
JPH06510764A (ja) ５−ｈｔ４レセプター・アンタゴニスト用のアザ二環式化合物
NZ246915A (en) Benzopyran, benzothiopyran and benzofuran derivatives, preparation and pharmaceutical compositions thereof
EP0937715B1 (fr) Composes de tetrahydrobenzindole
NO156055B (no) Fremgangsmaate ved fremstilling av anloept sortblikk av kvalitet t-3
DK159441B (da) 11-substituerede 5,11-dihydro-6h-dibenz(b,e)azepin-6-on-derivater, laegemidler indeholdende disse forbindelser og analogifremgangsmaade til forbindelsernes fremstilling
NO146359B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO150837B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive xanten- og tioxantenderivater
CS249545B2 (en) Method of phenylbenzo(b)thiophenic derivatives production
CA1102807A (fr) Traduction non-disponible
DE2256392A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
US4042695A (en) Thiaxanthene derivatives, compositions thereof and methods of treating therewith
DE2056590A1 (de) Morphohn und Piperazindenvate
DE3204157A1 (de) Substituierte dibenzodiazepinone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US3445464A (en) Phenothiazine derivatives
US3531480A (en) Phenothiazine derivatives
DE2014911A1 (de) Verfahren zur Herstellung von neuen Imidazolidinenderivaten
EP0000716B1 (fr) Dérivés de la pyrrolo(2,1-b)(3)benzazépine, procédé pour leur préparation et compositions pharmaceutiques les contenant
US4206210A (en) Alkylthio-7,8-dihdroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines having dopaminergic activity
DE2423721A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
DE1695730A1 (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen